4D Molecular Therapeutics's total assets for Q3 2024 were $604.03M, a decrease of -2.59% from the previous quarter. FDMT total liabilities were $51.08M for the fiscal quarter, a 60.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.